Akari Therapeutics Plc
SEC Filing List
AKTX CIK: 0001541157
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| POS AM | Post-effective amendment to a registrati... | Akari Therapeutics Plc | M2 COMPLIANCE LLC /fa | 04/10/2026 | |
| F-6/A | Amendment to Registration statement for ... | Deutsche Bank Trust Co Americas/ Adr Group | SEWARD & KISSEL LLP /fa | 03/31/2026 | |
| 10-K | Annual report pursuant to Section 13 and... | Akari Therapeutics Plc | M2 COMPLIANCE LLC /fa | 03/30/2026 | |
| 8-K | Current report filing | Akari Therapeutics Plc | M2 COMPLIANCE LLC /fa | 03/17/2026 | |
| 4 | Statement of changes in beneficial owner... | Neal James R | M2 COMPLIANCE LLC /fa | 03/16/2026 | |
| SCHEDULE 13D/A | M2 COMPLIANCE LLC /fa | 03/04/2026 | |||
| SCHEDULE 13G/A | M2 COMPLIANCE LLC /fa | 03/04/2026 | |||
| SCHEDULE 13D/A | M2 COMPLIANCE LLC /fa | 03/04/2026 | |||
| 8-K | Current report filing | Akari Therapeutics Plc | M2 COMPLIANCE LLC /fa | 03/02/2026 | |
| DEF 14A | Definitive proxy statements | Akari Therapeutics Plc | M2 COMPLIANCE LLC /fa | 02/02/2026 | |
| No record found. | |||||
| Load More | |||||
